Research Article

Feasibility of percutaneous nephrolithotomy after urology residency training in the 2nd stage state hospital

Volume: 15 Number: 2 April 1, 2022
EN TR

Feasibility of percutaneous nephrolithotomy after urology residency training in the 2nd stage state hospital

Abstract

Purpose: It was aimed to evaluate the results and complications of percutaneous nephrolithotomy (PCNL) in a second stage state hospital by a surgeon after Urology residency.
Materials and methods: Between January 2019 and January 2020, PCNL was applied to 102 renal units in 97
patients with kidney stones in a second stage state hospital. Standard PCNL was performed in all patients in the prone position with a 26 Fr rigid nephroscope and pneumatic lithotripter. The data of the patients were collected retrospectively. Success rates, length of stay, and complications were evaluated in the light of the literature.
Results: The average age of 97 patients who underwent PCNL was 41.7±10.5 (8-71) and 54 (55.7%) of these
patients were male and 43 (44.3%) were female. Access was provided to 102 renal units. 42 (41.2%) of them
were left and 60 (58.8%) were right. The mean stone surface area was 8.3±5.5 (2-34) cm2 and the number
of stones per patient was 2.4. Operation time was measured as 85>32 (40-170) minutes. The duration of
fluoroscopy was observed as 1.2±0.2 (0.5-9) minutes. The stone free rate was achieved in 86 (84.3%) of 102
cases. Including clinically insignificant residual fragments (>4 mm), the overall success rate was 93.1%. The
hospital stay of the patients was 2.7 (1-11) days. The number of patients with major and minor complications was 21 (20.6%).
Conclusion: We thought that PCNL can be applied safely and effectively in 2nd stage state hospitals with
acceptable complications and success rates in line by the literature.

Keywords

Supporting Institution

Çalışmaya yönelik herhangi bir teknik, finansal destek sağlanmamıştır.

Project Number

yok

Thanks

yok

References

  1. Fernström, I., and B. Johansson. "Percutaneous pyelolithotomy: a new extraction technique." Scandinavian journal of urology and nephrology 10.3 (1976): 257-259. https://doi.org/10.1080/21681805.1976.11882084
  2. Türk, C., et al. "Guidelines on urolithiasis." European association of urology (2011).
  3. de la Rosette, Jean JMCH, et al."Training in percutaneous nephrolithotomy a critical review." European urology 54.5 (2008): 994-1003. https://doi.org/10.1016/j.eururo.2008.03.052
  4. Bayar, Goksel, et al. "The effect of stone localization on the success and complication rates of percutaneous nephrolithotomy." Urology journal 11.06 (2014): 1938-1942. https://doi.org/10.22037/uj.v11i06.2507
  5. Bıçaklıoğlu, Fatih, Murat Yavuz Koparal, and Ender Cem Bulut. "Perkütan nefrolitotomi'ye 2. basamak devlet hastanesinde başlamak güvenli ve etkin mi?: ilk 60 vaka." Kocaeli Tıp Dergisi 8.1 (2019): 115-124. https://doi.org/10.5505/ktd.2019.05826
  6. Tefekli, Ahmet, et al. "Classification of percutaneous nephrolithotomy complications using the modified clavien grading system: looking for a standard." European urology 53.1 (2008): 184-190. https://doi.org/10.1016/j.eururo.2007.06.049
  7. Ramakumar, Sanjay, and Joseph W. Segura. "Renal calculi: percutaneous management." Urologic Clinics of North America 27.4 (2000): 617-622. https://doi.org/10.1016/S0094-0143(05)70111-7
  8. Rosette, Jean de la, et al. "The clinical research office of the endourological society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5803 patients." Journal of endourology 25.1 (2011): 11-17. https://doi.org/ 10.1089/end.2010.0424

Details

Primary Language

English

Subjects

Urology

Journal Section

Research Article

Publication Date

April 1, 2022

Submission Date

August 1, 2021

Acceptance Date

November 16, 2021

Published in Issue

Year 2022 Volume: 15 Number: 2

AMA
1.Sevim M, Alkış O, Kartal İ, Aras B. Feasibility of percutaneous nephrolithotomy after urology residency training in the 2nd stage state hospital. Pam Med J. 2022;15(2):337-343. doi:10.31362/patd.972916

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License